← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $1.6M of Moderna, Inc.

Sold$1,614,094
$107.61Price
15,000Shares

What MRNA did after the filing

Filed Sep 8Copier in Sep 11
The stock from Mon, Sep 11 open, $106.80
−26.4%
S&P 500, same days
−5.9%

Measured over 30 trading days, to the Oct 23 close.

Traded Wed, Sep 6. Filed Fri, Sep 8, 7:01 PM ET, after the close. Returns use the Sep 11 open and the Oct 23 close. Not investment advice.